Communications between Charlotte Taylor of the Antivirals and therapeutics TaskForce and the CMO
Louise Bicknell made this Freedom of Information request to Department of Health and Social Care
Dear Department of Health and Social Care,
For the period 1 April 2022 to 6 September 2022
All direct communications between Charlotte Taylor of the Antivirals and Therapeutics Taskforce and the Chief Medical Officer in which Evusheld (i.e. the combination of Tixagevimab and cilgavimab, AZD7742 or any other name that is used by the DHSC for this) is mentioned, whether by email or other electronic means.
Dear Ms Bicknell,
Please find attached the Department of Health and Social Care's response
to your recent FOI request (our ref: FOI-1429204).
Freedom of Information Team
Department of Health and Social Care
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.Donate Now